Trial Profile
A Phase 1, Open-Label, Mass Balance Study to Evaluate the Pharmacokinetics of ASP015K After a Single Oral Dose of 14C-Labeled ASP015K in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Aug 2011
Price :
$35
*
At a glance
- Drugs Peficitinib (Primary)
- Indications Psoriasis
- Focus Pharmacokinetics
- 04 Aug 2011 New trial record